Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma
Open Access
- 15 August 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (4) , 1553-1554
- https://doi.org/10.1182/blood-2003-04-1286
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphomaBlood, 2002
- BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expressionBlood, 2002
- T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10Blood, 2001
- Bcl10 Is a Positive Regulator of Antigen Receptor–Induced Activation of NF-κ B and Neural Tube ClosureCell, 2001
- BCL10 Expression in Normal and Neoplastic Lymphoid TissueThe American Journal of Pathology, 2000
- Chromosomal translocations are common in natural killer-cell lymphoma/leukemia as shown by spectral karyotypingHuman Pathology, 2000
- Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor TypesCell, 1999
- Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemiaBritish Journal of Haematology, 1997